NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E31.70 EPS (ttm)0.78 Insider Own50.12% Shs Outstand20.37M Perf Week0.24%
Market Cap1.00B Forward P/E11.02 EPS next Y2.25 Insider Trans0.02% Shs Float20.22M Perf Month7.60%
Enterprise Value1.70B PEG1.10 EPS next Q0.52 Inst Own50.28% Short Float4.49% Perf Quarter12.28%
Income31.79M P/S0.84 EPS this Y70.78% Inst Trans-2.16% Short Ratio3.86 Perf Half Y16.46%
Sales1.19B P/B3.77 EPS next Y10.65% ROA2.77% Short Interest0.91M Perf YTD17.95%
Book/sh6.56 P/C14.27 EPS next 5Y28.71% ROE11.86% 52W High26.55 -6.70% Perf Year39.63%
Cash/sh1.74 P/FCF20.47 EPS past 3/5Y-64.59% -46.42% ROIC3.15% 52W Low16.16 53.28% Perf 3Y38.46%
Dividend Est.0.48 (1.94%) EV/EBITDA10.34 Sales past 3/5Y6.89% 4.21% Gross Margin32.51% Volatility1.90% 1.76% Perf 5Y-4.33%
Dividend TTM0.48 (1.94%) EV/Sales1.43 EPS Y/Y TTM141.45% Oper. Margin10.27% ATR (14)0.79 Perf 10Y-25.77%
Dividend Ex-DateJun 04, 2025 Quick Ratio1.23 Sales Y/Y TTM19.12% Profit Margin2.67% RSI (14)60.81 Recom3.25
Dividend Gr. 3/5Y0.00% 0.85% Current Ratio2.91 EPS Q/Q147.30% SMA201.83% Beta0.74 Target Price22.25
Payout805.37% Debt/Eq2.89 Sales Q/Q32.14% SMA5013.17% Rel Volume0.61 Prev Close24.46
Employees1940 LT Debt/Eq2.80 EarningsMay 07 AMC SMA20011.07% Avg Volume235.22K Price24.77
IPOApr 11, 2014 Option/ShortYes / Yes EPS/Sales Surpr.21.04% -1.25% Trades Volume143,219 Change1.27%
Date Action Analyst Rating Change Price Target Change
Jun-16-25Upgrade BNP Paribas Exane Underperform → Neutral $24
Sep-10-24Initiated JP Morgan Neutral $22
Dec-07-23Initiated Exane BNP Paribas Underperform $9
Dec-21-22Initiated ROTH Capital Buy $18
Jul-25-22Downgrade Barclays Equal Weight → Underweight $22
Jan-10-22Upgrade Barclays Underweight → Equal Weight $23
Nov-18-21Initiated Morgan Stanley Equal-Weight $23
Aug-05-21Resumed Credit Suisse Neutral $25
Jul-07-21Downgrade Barclays Equal Weight → Underweight $23
Aug-06-20Downgrade Morgan Stanley Equal-Weight → Underweight $20
Today 09:33AM
Jun-23-25 12:45PM
Jun-20-25 11:30AM
Jun-19-25 08:35AM
Jun-18-25 09:22AM
08:28AM Loading…
08:28AM
Jun-17-25 09:40AM
08:39AM
Jun-16-25 08:27AM
08:25AM
07:26AM
Jun-13-25 12:13PM
11:40AM
11:34AM
11:21AM
09:40AM Loading…
09:40AM
08:27AM
Jun-12-25 09:15AM
Jun-11-25 09:51AM
08:35AM
Jun-10-25 08:06AM
Jun-09-25 08:37AM
Jun-06-25 11:31AM
09:50AM
09:02AM
Jun-05-25 08:52AM
Jun-04-25 08:34AM
05:26AM
Jun-03-25 03:00PM
10:09AM
08:08AM Loading…
08:08AM
Jun-02-25 10:23AM
10:18AM
08:12AM
May-30-25 10:09AM
09:27AM
08:16AM
May-29-25 09:40AM
09:31AM
08:54AM
08:47AM
May-28-25 12:45PM
11:40AM
09:40AM
09:22AM
08:12AM
May-27-25 08:15AM
May-26-25 08:38AM
08:30AM
08:30AM
May-23-25 09:52AM
08:53AM
04:50AM
04:37AM
03:42AM
May-22-25 04:00PM
06:46AM
06:38AM
May-21-25 12:00PM
11:36AM
09:50AM
09:10AM
07:49AM
May-20-25 08:53AM
08:49AM
May-19-25 08:38AM
May-16-25 07:47AM
06:34AM
May-15-25 08:40AM
May-14-25 07:11AM
May-13-25 09:40AM
09:16AM
07:48AM
May-12-25 12:45PM
11:40AM
09:40AM
May-09-25 03:25AM
May-08-25 08:13AM
May-07-25 08:30PM
07:40PM
06:33PM
04:30PM
May-06-25 04:15PM
May-01-25 10:01AM
Apr-30-25 10:01AM
Apr-24-25 09:40AM
Apr-23-25 04:00PM
Apr-22-25 11:25AM
Apr-16-25 11:40AM
09:40AM
09:35AM
Apr-11-25 09:35AM
Apr-10-25 11:36AM
Apr-09-25 12:45PM
08:57AM
08:39AM
Apr-08-25 09:57AM
09:40AM
Apr-04-25 08:09AM
Apr-02-25 07:27AM
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BFI Co., LLC10% OwnerMay 19 '25Proposed Sale24.00241,1295,787,096May 19 05:25 PM
CORCORAN E THOMASDirectorFeb 24 '25Buy22.105,000110,50030,000Feb 26 04:15 PM
BFI Co., LLC10% OwnerFeb 18 '25Proposed Sale25.77247,7696,385,007Feb 18 05:35 PM
CORCORAN E THOMASDirectorSep 04 '24Buy20.025,000100,10025,000Sep 06 04:34 PM
BFI Co., LLC10% OwnerAug 13 '24Proposed Sale17.29257,4004,450,446Aug 13 05:20 PM